Pruritus of Unknown Origin
📧 Sign up to get email alerts when something new happens for Pruritus of Unknown Origin.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC) [Phase 3]
A Phase 3 study (LIBERTY-CPUO-CHIC) is evaluating the efficacy and safety of subcutaneous dupilumab for chronic pruritus of unknown origin i…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO) [Phase 2]
Galderma R&D has launched a Phase 2 proof-of-concept study to characterize the pharmacokinetics and pharmacodynamics of nemolizumab in adult…